37 episodes
Pharma Launch Secrets Evermed
-
- Science
-
-
5.0 • 6 Ratings
-
Welcome to Pharma Launch Secrets, a podcast by Evermed. We host honest, direct, actionable conversations with world-leading pharma launch experts that will help you stay up to date with trends and strategies to help you launch your product successfully.
-
How Indegene Uses “Hybrid” Go-To-Market Model to Help Orchestra Omnichannel Pharma Launches for Their Clients
In this episode of Pharma Launch Secrets, Bozidar speaks with Nancy Phelan, senior VP at Indegene.
-
Greatest Hits: A Look Back on Five of the Best Pharma Launch Secrets Episodes
In this special compilation episode, we will take you back to revisit some of the most enlightening conversations, innovative strategies, and motivating stories since our beginning.
-
AI-Powered Compliant Content Creation at Scale: How Far Are We From Using Modular Content and Technology to Radically Transform Content Marketing in Pharma
In this episode, Bozidar speaks with Diana Lee, Co-Founder and CEO of Constellation Software Inc..
-
“Professors in the Hot Seat,” Novo Nordisk, Medical Education, and Pharma Launches: How the KOL Interview Format Unleashed Repeated Engagement and Education for Novo Nordisk
In this episode, Bozidar speaks with Jens Øllgaard, Head of Education, Novo Nordisk Denmark.
-
US Launches: How to Use Media Channels, Ads, GPT, Endemic, and Non-Endemic Channels to Be Relevant From Day 1 and Drive a Successful Launch
In this episode, Bozidar speaks with Kelly (Lundquist) Millett, SVP and Head of Health Strategy at Havas Media Network.
-
Content, GPT, MLR, and Medical Affairs: How to Make Medical Operations Future-Ready and Lead with Trust, Scientific Evidence, and Omnichannel?
In this episode, Bozidar speaks with Sameer Lal, SVP at Indegene.
Customer Reviews
Must listen for Med Affairs!
It was great to hear Meg Heim speaking about Medical Affairs planning and reframing cost as investment - love it
Outstanding series. Actionable intel.
Pharma launches are critical to the success and growth of companies large mid and small. They are very often make or break, and data show that more than 50% of launches fail to meet projections. This series offers global leaders speaking with Evermed CEO Dr Bozi Jovicevic, a 17-yr veteran of Novartis and Sanofi. Among the things you'll learn to understand better are the differences in launches in the US, EU, and JAPAC.
Great Idea
Pharma launch secrets is something that was missing in the market. It’s hard to find resources on this topic beyond classical IQVIA or McKinsey reports. Great idea.
Top Podcasts In Science